MENU
+Compare
PRRUF
Stock ticker: OTC
AS OF
Dec 11 closing price
Price
$0.27
Change
-$0.00 (-0.00%)
Capitalization
368.36M

PRRUF Immutep Ltd. Forecast, Technical & Fundamental Analysis

Immutep Ltd is a Phase three clinical biotechnology company developing novel Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease... Show more

PRRUF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for PRRUF with price predictions
Dec 11, 2025

PRRUF in downward trend: price may drop because broke its higher Bollinger Band on December 08, 2025

PRRUF broke above its upper Bollinger Band on December 08, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 20 similar instances where the stock broke above the upper band. In of the 20 cases the stock fell afterwards. This puts the odds of success at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 46 cases where PRRUF's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on December 08, 2025. You may want to consider a long position or call options on PRRUF as a result. In of 48 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PRRUF just turned positive on December 08, 2025. Looking at past instances where PRRUF's MACD turned positive, the stock continued to rise in of 32 cases over the following month. The odds of a continued upward trend are .

PRRUF moved above its 50-day moving average on December 08, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for PRRUF crossed bullishly above the 50-day moving average on December 10, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PRRUF advanced for three days, in of 24 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PRRUF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.070) is normal, around the industry mean (28.362). P/E Ratio (0.000) is within average values for comparable stocks, (51.986). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.836). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (336.196).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PRRUF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
PRRUF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
264 George Street
Phone
+61 283157003
Employees
24
Web
https://www.immutep.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IDPIX79.751.22
+1.55%
ProFunds Industrial Ultra Sector Inv
JHERX20.980.16
+0.77%
JHancock Equity Income C
TQMIX19.080.13
+0.69%
AMG TimesSquare Mid Cap Growth I
VGENX51.90-0.11
-0.21%
Vanguard Energy Inv
MIEGX12.80-0.07
-0.54%
BNY Mellon Emerging Markets Inv

PRRUF and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PRRUF has been loosely correlated with IMMP. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PRRUF jumps, then IMMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRRUF
1D Price
Change %
PRRUF100%
+2.95%
IMMP - PRRUF
43%
Loosely correlated
+5.20%
CALC - PRRUF
24%
Poorly correlated
+0.66%
PHGUF - PRRUF
21%
Poorly correlated
N/A
PVCT - PRRUF
11%
Poorly correlated
-0.31%
OXBDF - PRRUF
9%
Poorly correlated
N/A
More